Algorithmic Biologics focuses on enhancing molecular diagnostics and discovery through innovative software solutions, particularly their Tapestry technology. This platform acts as a molecular search engine, significantly reducing the number of tests required for large sample sizes while maintaining high accuracy. For instance, instead of conducting 1,000 individual tests for samples needing triplicate testing, Tapestry can achieve the same results with only 100 tests. This is accomplished through a preprocessing step that ensures each sample is represented multiple times in pooled tests, followed by an AI-driven deconvolution process that aligns the results with individual testing outcomes. The technology is versatile, compatible with various molecular testing methods such as PCR, sequencing, and mass spectrometry.

The Tapestry system not only streamlines testing but also offers substantial cost savings, with reported reductions in library preparation costs exceeding 60%. Algorithmic Biologics has successfully validated this technology through partnerships with leading genomics research labs and has received regulatory approvals, including CE marking for in vitro diagnostics. Their approach is backed by a transdisciplinary team of AI and biotech experts, and their innovations have garnered attention from prominent scientific publications, highlighting their commitment to making advanced molecular testing more accessible and efficient in healthcare.

India

Algorithmic Biologic's vision is to create a bountiful and healthy world by bringing scale efficiencies to molecular discovery and diagnostics.

Our transdisciplinary team has a deep modeling-based understanding of the chemistry and mechanics of molecular technologies. 

Our first product, Tapestry, is award-winning, regulatory approved algorithmic solution to provide affordable large-scale COVID-19 testing.

Algorithmic Biologics

Company Details